Metolazone - Oedema

You are here : Home > Formulary Search > Metolazone - Oedema

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue

Formulations :

Tablets

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

BNF SPC

Restrictions / Comments :

Important

Prescribing in primary care on recommendation of specialist team only. The licensed (Xaqua) and unlicensed (Zaroxolyn) tablets have different bioavailabilities. These products are not interchangable=Prescribe by Brand

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Metolazone

Indication :

Oedema

Group Name :

Keywords :

Brand Names Include :

Important Information :

The licensed (Xaqua) and unlicensed (Zaroxolyn) tablets have different bioavailabilities. These products are not interchangable=Prescribe by Brand

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Metolazone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Oedema.

Committee Recommendations (1)

07 Aug 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.